Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Hodgkin lymphoma, Lymphoma
Closed
This trial is looking at having avelumab before standard chemotherapy for Hodgkin lymphoma.
It is for people:
recently diagnosed with advanced Hodgkin Lymphoma
who haven’t had treatment yet
Advanced Hodgkin Lymphoma is stage 2 lymphoma with symptoms such as night sweats. Or lymphoma that is more widespread (stage 3 or stage 4).
Recruitment start: 27 September 2019
Recruitment end: 4 May 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Graham Collins
Pfizer
University College London (UCL)
Cancer Research UK & UCL Cancer Trials Centre
Last reviewed: 18 May 2022
CRUK internal database number: 15565
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
